Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Promoter hypermethylation in plasma‐derived cell‐free DNA as a prognostic marker for pancreatic adenocarcinoma staging

31 Aug 2017

Abstract excerpt

Correct staging of pancreatic cancer is paramount, as treatment is stage specific. However, minimally invasive tools to facilitate staging are lacking. DNA promoter hypermethylation is a hallmark of cancer. The aim of this study is to evaluate promoter hypermethylation in cell-free DNA as a prognostic marker for stage classification of pancreatic adenocarcinoma. Consecutive patients with pancreatic adenocarcinoma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Epigenetics and DNA Methylation
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28857158
DOI: 10.1002/ijc.31024

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Promoter hypermethylation in plasma‐derived cell‐free DNA as a prognostic marker for pancreatic adenocarcinoma stagingPMID 28857158Read ↗

Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinomaSemantic proximity Read ↗

Cell-Free DNA Methylation as Blood-Based Biomarkers for Pancreatic Adenocarcinoma—A Literature UpdateSemantic proximity Read ↗

Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNASemantic proximity Read ↗

Genome-Wide Analysis of Cell-Free DNA Methylation Profiling for the Early Diagnosis of Pancreatic CancerSemantic proximity Read ↗

Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers’ DiscoverySemantic proximity Read ↗

Cell-free DNA promoter hypermethylation as a diagnostic marker for pancreatic ductal adenocarcinoma – An external validation studySemantic proximity Read ↗

Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic CancerSemantic proximity Read ↗

Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNASemantic proximity Read ↗

Survival Analysis of Multi-Omics Data Identifies Potential Prognostic Markers of Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Deciphering DNA methylation signatures of pancreatic cancer and pancreatitisSemantic proximity Read ↗

Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancerSemantic proximity Read ↗

Advances in pancreatic cancer epigenetics: From the mechanism to the clinicSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.